GLP-1 Microdosing For Weight Loss: Noom CEO Explains Their New Program
Update: 2025-08-13
Description
GLP-1 microdosing is one of the hottest and most controversial topics in obesity medicine right now. Can lowering your dose instead of quitting completely help you keep the weight off? In this exclusive interview, Noom CEO Geoff Cook responds to questions about microdosing, GLP-1 off-ramping, and how Noom supports patients using medications like Mounjaro, Zepbound, Wegovy, and Ozempic.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
